Buzzy Application During Heel Blood Collection in the Newborn

Yuzuncu Yıl University

Status

Completed

Conditions

Buzzy

Treatments

Behavioral: Buzzy application

Study type

Interventional

Funder types

Other

Identifiers

NCT06773325

Buzzy

Details and patient eligibility

About

Objective The aim of this study was to evaluate the effects of Buzzy device application during heel prick blood collection on pain level and comfort in newborns.

Method. The study was conducted in a Family Health Center affiliated to the Public Health Directorate of a province in eastern Turkey between September and November 2024 using a randomized controlled experimental design. The study sample consisted of 80 newborn infants born at 37-42 weeks gestational age and within the first 28 days of birth (Buzzy group: n = 40, control group: n = 40). The Buzzy group was treated by placing the Buzzy device approximately 30 seconds before heel prick blood collection. In the control group, routine heel prick was performed without any application. Neonatal introduction form, Neonatal Infant Pain Scale and Neonatal Comfort Behavior Scale were used for data collection.

Enrollment

80 patients

Sex

All

Ages

Under 28 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Those in the neonatal period between 0-28 days,
voluntary participation of the parent,
between 37-42 weeks of gestational age
babies with vital signs within normal limits

Exclusion criteria

The integrity of the skin in the area where the device was to be implanted was compromised,
Nerve damage or deformity in the extremity to be heel bled,
Genetic - with a congenital anomaly or congenital metabolic disorder,
undergoing cardiopulmonary resuscitation,
No heel prick on the first attempt,
with osteogenesis imperfecta and infants given analgesics in the last 6 hours